Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
[Bacteriological substantiation of the antituberculosis effect of immunotropic drug tubosan].
Kibrik BS, Pavlov AV, Chelnokova OG. Kibrik BS, et al. Eksp Klin Farmakol. 2013;76(2):20-2. Eksp Klin Farmakol. 2013. PMID: 23631279 Russian.
Results of this study show that tubosan possesses both antituberculosis and immunostimulant properties. It is recommended to use tubosan for complex treatment of patients with drug-resistant tuberculosis....
Results of this study show that tubosan possesses both antituberculosis and immunostimulant properties. It is recommended to use t
[Experimental estimation of immunomodulating activity of Tubosan, a new Russian synthetic drug].
Chernikova NK, Mikhailov VV, Borisevich SV. Chernikova NK, et al. Antibiot Khimioter. 2014;59(9-10):13-6. Antibiot Khimioter. 2014. PMID: 25975110 Russian.
Tubosan, a new Russian immunostimulator is a derivative of sulfopyrimidine. It stimulated the humoral antiviral immunity in mice, provoked increasing the number of the antibody forming cells in the spleen of mice, immunized by sheep's erythrocytes, and increased the titers
Tubosan, a new Russian immunostimulator is a derivative of sulfopyrimidine. It stimulated the humoral antiviral immunity in mice, pro
[Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide].
Kibrik BS, Chelnokova OG, Terekhina LM, Sosnina OIu. Kibrik BS, et al. Antibiot Khimioter. 2012;57(11-12):16-21. Antibiot Khimioter. 2012. PMID: 23700932 Clinical Trial. Russian.
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class of immunotropic agents were investigated with the use of 78 clinical isolates of Mycobacterium tuberculosis (MBT). …
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of …